Palantir Technologies Inc. - Class A Common Stock (PLTR)

Last Price184.36

Change+0.25 (0.14%)

NASDAQ · Last Trade: Nov 2nd, 12:40 PM EST

Quote News Press Releases Chart Historical FAQ About Competitors

Detailed Quote

Previous Close	184.11
Open	186.52
Bid	184.32
Ask	184.36
Day's Range	181.63 - 187.55
52 Week Range	106.37 - 212.94
Volume	13,525,087
Market Cap	373.79M
PE Ratio (TTM)	158.93
EPS (TTM)	1.2
Dividend & Yield	N/A (N/A)
1 Month Average Volume	22,842,170

Chart

About Palantir Technologies Inc. - Class A Common Stock (PLTR)

Palantir Technologies is a public software company that specializes in big data analytics and provides platforms for organizations to integrate, visualize, and analyze large amounts of data from disparate sources. Its flagship products, Palantir Gotham and Palantir Foundry, are designed to assist government agencies and commercial enterprises in making data-driven decisions by offering advanced analytical capabilities, collaborative tools, and visualization features. The company has gained prominence for its work with intelligence and defense organizations, as well as its growing presence in various industries such as finance, healthcare, and manufacturing, enabling clients to derive actionable insights and enhance their operational efficiency. Read More

News & Press Releases

After Posting Strong Q3 Numbers, Is BigBear.ai Stock Due for a Rally?fool.com

The tech stock is down big this year, but it may have recently given investors a reason to be more bullish moving forward.

Via The Motley Fool · November 2, 2026

Why Napco (NSSC) stock is nosediving

What happened? Shares of security systems manufacturer Napco (NASDAQ:NSSC) fell 17.3% in the morning session after the company reported its third-quarter 202...

Via StockStory · November 2, 2026

Inovio Wins FDA Approval for VOCERYQ, Its First Commercial Productmarketbeat.com

Inovio Pharmaceuticals (NASDAQ:INO) said the U.S. Food and Drug Administration granted accelerated approval to VOCERYQ, formerly known as INO-3107, as a nonsurgical treatment intended to reduce the frequency of surgeries in adults with recurrent respiratory papillomatosis, or RRP. VOCERYQ is the co

Via MarketBeat · November 2, 2026

Palantir Stock Is Trading at 165 Times Earnings. Can Growth Justify It?fool.com

Palantir's next earnings report could answer crucial questions about its growth and valuation. Discover the financial measures that may determine whether its impressive momentum can continue.

Via The Motley Fool · November 2, 2026

Talos Energy (TALO) to report earnings tomorrow: here is what to expect

Offshore energy producer Talos Energy (NYSE:TALO) will be announcing earnings results tomorrow after market hours. Here’s what to expect. Talos Energy beat a...

Via StockStory · November 2, 2026

Amneal (AMRX) Q3 earnings: what to expect

Pharmaceutical company Amneal Pharmaceuticals (NASDAQ:AMRX) will be reporting results tomorrow before market hours. Here’s what to expect. Amneal beat analys...

Via StockStory · November 2, 2026

Palantir Earnings On Tap. Can Software Maker Buck AI Sell-Off?investors.com

Palantir earnings are due late Monday with sales growth seen slowing, finally.

Via Investor's Business Daily · November 2, 2026

Procore Technologies (PCOR) to report earnings tomorrow: here is what to expect

Construction management software provider Procore Technologies (NYSE:PCOR) will be reporting earnings this Tuesday after market close. Here’s what you need t...